The Worlds #1 Renewable Energy Network for News & Information
Sign In
or
Register
Sections
Home
Solar
Wind
Geothermal
Bio
Hydro
Careers
Companies
Webcasts
White Papers
Magazines
Awards
Account
Sign In
Register
Search
REW 40 Index
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Bristol-Myers Squibb Co.
(NY:
BMY
)
47.00
USD
+0.60 (+1.29%)
Official Closing Price
/ Updated:
6:40 PM EDT, May 23, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Blog posts about Bristol-Myers Squibb Co.
< Previous
1
2
3
4
5
6
7
8
9
...
30
31
Next >
Gilead Clinches Pharmasset Buy
January 19, 2012
Gilead Sciences, Inc. (NASDAQ:GILD) announced recently that it has completed its previously announced agreement to buy Pharmasset, Inc, a maker of drugs for the treatment of chronic hepatitis C virus...
Read More
category
RHHBY
,
INHX
,
External Research
, and 6 more.
from
DailyMarkets.com
Bristol-Myers/AstraZeneca Get CRL
January 19, 2012
Recently, Bristol-Myers Squibb (NYSE:BMY) and partner AstraZeneca (NYSE:AZN) suffered a pipeline setback when the US Food and Drug Administration (FDA) declined to approve their type II diabetes...
Read More
category
Stocks
,
External Research
,
Contributor
from
DailyMarkets.com
Stocks Gain for the Week Despite EU Jitters (AA, AAPL, BAC, CVX, FSLR, JPM, NFLX, TIF, URBN, WSM)
January 14, 2012
Weston, January 14th (Tradershuddle.com) – Stocks gained for the week, extending their January week and posting the second consecutive weekly gain for the year. Economic optimism amid a decent outlook...
Read More
from
TradersHuddle.com
Stocks Gained ahead of Earnings (AAPL, BAC, CBE, GOOG, INHX, JNPR, JPM, NFLX, RF, TRV, WFC)
January 09, 2012
New York, January 9th (TradersHuddle.com) – Stocks closed with modest gains, extending the solid gains from the first week of the year, ahead of a brand new earnings season. Participants focused on...
Read More
from
TradersHuddle.com
Hot Option Plays: Tight Range Consolidation
January 09, 2012
Cusick’s Corner 01-09-2012 Tight range consolidation continues into the Midday. With earnings starting to kick off and meetings in the EU being discussed, the market is content with staying in these...
Read More
category
Options
,
GM
,
REE
, and 14 more.
from
DailyMarkets.com
(DUK) 2012 Predictions for Income Investors
January 09, 2012
by Marc Lichtenfeld, Investment U Senior Analyst Wednesday, December 28, 2011: Issue #1674 Last... Visit StockBlogHub to view complete post.
Read More
category
DUK
,
Microsoft Corporation
,
Apple Inc/
, and 13 more.
from
Stock Blog Hub
(ATHN) Grading the Investment U Gurus 2011: Marc Lichtenfeld
January 09, 2012
by Marc Lichtenfeld, Investment U Senior Analyst Tuesday, December 20, 2011: Issue #1668 I’m... Visit StockBlogHub to view complete post.
Read More
category
VFC
,
ATI
,
ABT
, and 37 more.
from
Stock Blog Hub
(BMY) Bristol-Myers Squibb Company Kicks Off 2012 Pharma Deals
January 09, 2012
The spate of acquisitions in the pharma industry continues in 2012 with Bristol-Myers Squibb... Visit StockBlogHub to view complete post.
Read More
category
VRUS
,
Sanofi/Aventis
,
Johnson & Johnson
, and 15 more.
from
Stock Blog Hub
Stock Futures Higher ahead of Earnings. Stocks to Watch: AA, AAPL, BAC, BMY, GSK, NFLX, RL, TRV
January 09, 2012
New York, January 9th (TradersHuddle.com) – Stock futures were pointing to higher open ahead of the start of a new earnings season and ahead of the first meeting of the year for German Chancellor...
Read More
from
TradersHuddle.com
BMY Kicks Off 2012 Pharma Deals
January 09, 2012
The spate of acquisitions in the pharma industry continues in 2012 with Bristol-Myers Squibb Company (NYSE:BMY) announcing the first major deal of the new year. Major merger and acquisition (M&A) deals...
Read More
category
VRUS
,
INHX
,
External Research
, and 8 more.
from
DailyMarkets.com
(BMY) Company News for January 04, 2012 – Corporate Summary
January 08, 2012
• Share prices of natural gas producer Devon Energy Corp (NYSE:DVN) gained 6.63% after the... Visit StockBlogHub to view complete post.
Read More
category
RMBS
,
MJN
,
SNP
, and 15 more.
from
Stock Blog Hub
Change At Teva’s Helm
January 05, 2012
Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) recently announced a leadership change with current President and CEO, Shlomo Yanai, expected to retire from the company effective May 2012. Mr. Yanai...
Read More
category
NVS
,
TEVA
,
Stocks
, and 3 more.
from
DailyMarkets.com
The Q1 2012 FDA Trades
January 04, 2012
Be in the right place at the right time
Read More
from
Wealth Daily
Bears taking over - Bristol-Myers Squibb?
January 04, 2012
New York, January 4th (TradersHuddle.com) - Bristol-Myers Squibb Company ( NYSE:BMY ) shares closed the session lower by $0.23 or -0.65% from its previous close. Bristol-Myers Squibb's latest price...
Read More
from
TradersHuddle.com
Stock Market News Briefs: Bristol-Myers Squibb Company, Devon Energy, MGIC Investment, Rambus, China Petroleum & Chemical, Teva Pharmaceutical Industries Limited, USX Corporation
January 04, 2012
Share prices of natural gas producer Devon Energy Corp (NYSE:DVN) gained 6.63% after the company announced it would sell a stake in five of its exploratory projects across the U.S., to Sinopec...
Read More
category
MJN
,
X
,
SNP
, and 8 more.
from
DailyMarkets.com
Trade Alert - Bristol-Myers Squibb at New Highs
December 30, 2011
New York, December 30th (TradersHuddle.com) - Shares of Bristol-Myers Squibb Company ( NYSE:BMY ) booked a new 52 week high today by trading above $35.35, traders are definitely monitoring...
Read More
from
TradersHuddle.com
(JNJ) Pharma & Biotech Stock Review & Outlook – Industry Outlook
December 29, 2011
With 2011 coming to an end, the pharmaceutical industry continues to face challenges like sluggish... Visit StockBlogHub to view complete post.
Read More
category
Mylan Inc/
,
Glaxosmithkline plc
,
ALKS
, and 41 more.
from
Stock Blog Hub
Analyst Interviews: Pharma & Biotech Stock Review & Outlook
December 28, 2011
With 2011 coming to an end, the pharmaceutical industry continues to face challenges like sluggish prescription trends, EU pricing pressure, intensifying generic competition, pipeline failures and...
Read More
category
ALKS
,
TEVA
,
FRX
, and 21 more.
from
DailyMarkets.com
(BMY) Bristol-Myers Squibb Sees Pipeline Setback
December 24, 2011
Bristol-Myers Squibb Company (BMY) recently suffered a pipeline setback with its oncology... Visit StockBlogHub to view complete post.
Read More
category
Onyx Pharmaceuticals Inc
,
Sanofi/Aventis
,
ELEMENTS BG Small Cap ETN
, and 7 more.
from
Stock Blog Hub
Pipeline Setback At Bristol-Myers
December 23, 2011
Bristol-Myers Squibb Company (NYSE:BMY) recently suffered a pipeline setback with its oncology candidate, brivanib, performing disappointingly in a late-stage study (BRISK-PS). The study evaluated...
Read More
category
SNY
,
Stocks
,
External Research
, and 3 more.
from
DailyMarkets.com
Pipeline Progress At Alkermes
December 22, 2011
Alkermes plc (NASDAQ:ALKS) recently announced the commencement of a phase III study (n~690) to evaluate its schizophrenia candidate ALKS 9070. ALKS 9070 is a once-monthly injectable extended release...
Read More
category
ELN
,
ALKS
,
Stocks
, and 3 more.
from
DailyMarkets.com
Pipeline Progress At Alkermes
December 21, 2011
Alkermes plc (NASDAQ:ALKS) recently announced the commencement of a phase III study (n~690) to evaluate its schizophrenia candidate ALKS 9070. ALKS 9070 is a once-monthly injectable extended release...
Read More
category
ELN
,
ALKS
,
Stocks
, and 3 more.
from
DailyMarkets.com
(ATHN) Grading the Investment U Gurus 2011: Marc Lichtenfeld
December 21, 2011
by Marc Lichtenfeld, Investment U Senior Analyst Tuesday, December 20, 2011: Issue #1668 I’m... Visit StockBlogHub to view complete post.
Read More
category
VFC
,
ATI
,
ABT
, and 37 more.
from
Stock Blog Hub
Gilead’s Candidate Under EMA Review
December 21, 2011
Gilead Sciences Inc. (NASDAQ:GILD) announced recently that the European Medicines Agency (EMA) has accepted for review the marketing authorisation application (MAA) filed by the company for its HIV...
Read More
category
Stocks
,
External Research
,
Contributor
, and 2 more.
from
DailyMarkets.com
6 Stocks Hitting New Highs
December 19, 2011
WINDERMERE, Fla. ( Stockpickr ) -- At Stockpickr, we track daily portfolios of stocks that are hitting new 52-week highs and 52-week lows. When you see a stock that's . Read More --
Read More
from
TradersHuddle.com
Bristol-Myers Squibb Booked a New High
December 16, 2011
New York, December 16th (TradersHuddle.com) - Shares of Bristol-Myers Squibb Company ( NYSE:BMY ) booked a new 52 week high today by trading above $34.4, traders are definitely monitoring Bristol-Myers...
Read More
from
TradersHuddle.com
Bristol-Myers Squibb Booked a New High
December 15, 2011
New York, December 15th (TradersHuddle.com) - Shares of Bristol-Myers Squibb Company ( NYSE:BMY ) booked a new 52 week high today by trading above $33.85, traders are definitely monitoring...
Read More
from
TradersHuddle.com
Bristol-Myers, Simcere Extend Ties
December 14, 2011
Recently, Bristol-Myers Squibb Company (NYSE:BMY) announced that it has expanded its partnership with the Chinese pharmaceutical company Simcere Pharmaceutical Group (NYSE:SCR). Per the terms of the...
Read More
category
SCR
,
Stocks
,
External Research
, and 2 more.
from
DailyMarkets.com
Gilead Presents Elvitegravir Data
December 12, 2011
Gilead Sciences, Inc. (NASDAQ:GILD) recently announced positive long-term data from a late-stage pivotal trial (study 145) evaluating its HIV pipeline candidate elvitegravir. The study assessed the...
Read More
category
MRK
,
Stocks
,
External Research
, and 3 more.
from
DailyMarkets.com
Bristol-Myers Presents Data
December 09, 2011
Bristol-Myers Squibb Company (NYSE:BMY) and partner AstraZeneca (NYSE:AZN) recently presented data from a late-stage study which evaluated their candidate dapagliflozin in adults suffering from type II...
Read More
category
Stocks
,
External Research
,
Contributor
from
DailyMarkets.com
< Previous
1
2
3
4
5
6
7
8
9
...
30
31
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here